You have 9 free searches left this month | to do more
Showing 1 - 25 of
559 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
T
Phase 1b/2 Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib
Not yet recruiting
  • Myelofibrosis
  • +3 more
  • (no location specified)
2022-03-05
Mar 5, 2022
O
A Study to Determine the Efficacy and Safety of Two Mometasone Dry Powder Inhalers in the Treatment of Asthma (Study P02524) - 2003
Completed
  • Asthma
  • MF
  • (no location specified)
2022-02-01
Feb 1, 2022
x
Outcomes of MF Patients Exposure to Ruxolitinib During Transplantation
Recruiting
  • Time of Hematopoietic Reconstruction
  • comprehensive treatment regimen
  • Guangzhou, Guangdong, China
    NanfangH
2021-09-02
Sep 2, 2021
S
Jaktinib and Azacitidine In Treating Patients With MDS With MF or MDS/MPN With MF.
Not yet recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • (no location specified)
2021-11-29
Nov 29, 2021
N
Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF - 2020
Completed
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Scottsdale, Arizona
  • +8 more
2022-02-10
Feb 10, 2022
E
Study of Photopheresis in the Treatment of Erythrodermic MF and SS
Withdrawn
  • Lymphoma, T-Cell, Cutaneous
  • Mycosis Fungoides/Sezary Syndrome
  • Zürich, Switzerland
    UniversitaetsSpital Zurich - Division of Dermatology
2021-08-31
Aug 31, 2021
O
Study of Efficacy and Long-Term Safety of Mometasone Furoate in Combination With Formoterol Fumarate Versus Mometasone Furoate in Children (5 to 11 Years of Age) With Persistent Asthma (MK-0887A-087) - 2017
Completed
Has Results
  • Asthma
  • MF MDI 100 mcg BID (Open Label)
  • +4 more
  • (no location specified)
2022-02-07
Feb 7, 2022
J
MPN-RC 118 AVID200 in Myelofibrosis
Active, not recruiting
  • Primary Myelofibrosis
  • +4 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
2021-05-19
May 19, 2021
U
Ruxolitinib and Pomalidomide Combination Therapy in Patients With Primary and Secondary MF
Active, not recruiting
  • Primary Myelofibrosis
  • +5 more
  • Aachen, Germany
  • +16 more
2021-09-28
Sep 28, 2021
O
Asthma Study Comparing Anti-Inflammatory Effects of 3 Doses of Mometasone Furoate/Formoterol Fumarate and Medium Dose Mometasone Furoate (Study P05122 AM1)(COMPLETED) - 2009
Completed
Has Results
  • Asthma
  • Airway Inflammation
  • mometasone furoate/formoterol 100/10 mcg
  • +5 more
  • (no location specified)
2022-02-07
Feb 7, 2022
B
A Study to Evaluate a Mid Add Multi-Focal Soft Contact Lens - 2013
Completed
Has Results
  • Presbyopia
  • LD127025 MF
  • Air Optix Aqua MF
  • Rochester, New York
    Bausch & Lomb Incorporated
2020-09-09
Sep 9, 2020
K
KRT-232 in Combination With TL-895 for the Treatment of R/R MF and KRT-232 for the Treatment of JAKi Intolerant MF
Recruiting
  • Myelofibrosis
  • +3 more
  • Whittier, California
  • +8 more
2021-06-11
Jun 11, 2021
O
A Study of the Equivalent Effectiveness of 400 mcg Mometasone Furoate Using Two Different Dry Powder Inhalers in Moderate Asthmatics (Study P04828) - 2009
Completed
Has Results
  • Asthma
  • Mometasone furoate dry powder inhaler
  • Placebo
  • (no location specified)
2022-02-07
Feb 7, 2022
C
Clinical Evaluation of Biofinity Multifocal Compared With Air Optix Aqua Multifocal and With PureVision Multifocal - 2012
Completed
Has Results
  • Presbyopia
  • BIOFINITY® MF - AIR OPTIX® AQUA MF
  • BIOFINITY® MF - PUREVISION® MF
  • (no location specified)
2020-07-28
Jul 28, 2020
C
Deep Phenotyping of Cutaneous T Cell Lymphoma, Type Mycosis Fungoides
Recruiting
  • Mycosis Fungoides
  • Leiden, Netherlands
    Centre for Human Drug Research
2022-03-29
Mar 29, 2022
N
MAP to Provide Access to Ruxolitinib, for Patients With PMF or PPV MF or PET-MF
Available
  • Primary Myelofibrosis (PMF)
  • +2 more
  • (no location specified)
2022-01-18
Jan 18, 2022
K
An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 Combined With Ruxolitinib in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Or Post-Essential Thrombocythemia MF (Post ET-MF) Who Have a Suboptimal Response to Ruxolitinib
Recruiting
  • Myelofibrosis
  • Duarte, California
  • +32 more
2021-10-27
Oct 27, 2021
T
Skills Learning and Self-confidence in Learning in High-fidelity Simulation
Recruiting
  • Problem-solving
  • +2 more
  • Structured guideline
  • Kowloon, Hong Kong
    Florence MF Wong
2022-02-19
Feb 19, 2022
K
Study of Tagraxofusp for Post-Transplant Maintenance for Patients With CD 123+ AML, MF and CMML (HSCT 002)
Not yet recruiting
  • Myelofibrosis
  • +2 more
  • Charlottesville, Virginia
    Danyelle Coley
2022-01-31
Jan 31, 2022
J
A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors
Recruiting
  • NSCLC
  • +7 more
  • Tianjin, Tianjin, China
    Tianjin
2022-03-11
Mar 11, 2022
O
A Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis (Study P04512) - 2005
Completed
Has Results
  • Perennial Allergic Rhinitis
  • Placebo for MF
  • +3 more
  • (no location specified)
2022-02-07
Feb 7, 2022
H
A Phase 2 Study of RO7490677 In Participants With Myelofibrosis - 2020
Completed
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Phoenix, Arizona
  • +22 more
2021-12-07
Dec 7, 2021
T
Safety of SP-420 in the Treatment of Transfusional Iron Overload
Recruiting
  • Iron Overload
  • San Antonio, Texas
    Mays Cancer Center, UT Health San Antonio
2021-06-22
Jun 22, 2021
N
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory NHL, RT, MM, T-PLL, Acute Leukemia (AML, ALL), MDS, MDS/MPN, and MF
Recruiting
  • Non Hodgkin Lymphoma
  • +8 more
  • Chicago, Illinois
  • +1 more
2022-02-14
Feb 14, 2022
T
Immunogenicity of Alternative Annual Influenza Vaccination Strategies in Older Adults in Hong Kong
Active, not recruiting
  • Influenza, Human
  • Standard inactivated influenza vaccine (NH formulation)
  • +3 more
  • Hong Kong, China
    The University of Hong Kong
2021-09-24
Sep 24, 2021